Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
ADCs
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
3D Cell Culture
Optimising Cell Culture by Tackling Translational Barriers Through Automation and 3D Models
Explore how industry experts and top academics are addressing shortcomings of traditional cell culture
Antibody / Protein Production & Purification
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Immunotherapy (Non-Oncology)
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Cell-based Therapies
University College London Hospitals Begins Clinical Trial for One-Off CAR T Treatment for Lupus
The possibility of a one-off treatment for lupus could offer hope to 69,000 patients in the UK.
Antibody-based Therapies
Clesrovimab Shows Positive Results as Preventative Treatment for RSV in Pre-Term and Full-Term Infants
The phase IIb/III met both its primary and secondary endpoints in infants one year old or younger.
Regulatory
The NIST Awards $1.5 Million to Improve Standardisation in Regenerative Medicine
The National Institute of Standards and Technology (NIST) has given $1.5 million to two organisations to enhance regenerative medicine standards.
NextGen Therapeutics
Archon Biosciences Announces $20m of Seed Funding for its Nobel-Winning, AI-Driven Antibody Cage Technology
This investment signals the UW spin out’s ‘emergence from stealth’, showcasing their unique antibody platform.
